Our results demonstrated that BCR engagement (anti-IgM ligation) concomitant to CD40 ligand, IL-4 and IL-21 stimulation allowed CLL cells proliferation ex vivo. This evidence concerns the gene CD40LG and B-cell chronic lymphocytic leukemia.